A dietary supplement for the management of patients with lumbar osteochondrosis

Austrian Research group for Regenerative and Orthopedic Medicine (AURROM)0 个研究点目标入组 50 人开始时间: 2021年4月28日最近更新: 2023年1月9日

试验速览

暂无简介。

•1. Patients with asymptomatic (VAS = 3) MRI-confirmed (Pfirrmann grades 1 and 5 lumbar osteochondrosis
•2. Patients with pathologies including
•2.1. Rheumatoid osteoarthritis
•2.2. Fibromyalgia
•2.3. Scoliosis
•2.4. Neurological deficit
•2.5. Morbid adiposity (body mass index, BMI =40)
•2.6. Any other current or past clinically significant disease (comorbidity) that, in the opinion of the orthopaedic consultant, might confound the results of the study or poses an additional risk to the subject during participation in the study (e.g. renal, neoplastic, epigastric disease)
•3. Previous surgeries of intervertebral disc(s), hip(s)
•4. Allergies/intolerances against any component of the dietary supplement (e.g. shellfish)
•5. Pregnant or lactating women
•6. Not fluent (read/understand) in German (consent, questionnaires, and study forms are in German)
•7. Not able to undergo MRI (e.g. claustrophobia, pacemaker)

发起方

Austrian Research group for Regenerative and Orthopedic Medicine (AURROM)